Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
---|
12/29/2004 | CN1182103C Novel ethylamine derivatives |
12/29/2004 | CN1181817C NF-KB inhibitors containing phenylmethyl benzoquinone as active ingredient |
12/28/2004 | US6835851 Process for synthesizing N-(mercaptoacyl) amino acid derivatives from alpha-substituted acrylic acids |
12/28/2004 | US6835841 Asymmetric catalytic hydrogenation process for preparation of chiral cyclic β-aminoesters |
12/28/2004 | US6835734 1,3-dioxolanes with antitussive activity |
12/23/2004 | WO2004110986A1 Benzamide derivative or salt thereof |
12/23/2004 | WO2004110973A1 Anti-tumour platinum (ii) complexes with camphoric radicals as ligands |
12/23/2004 | US20040260095 human immunodeficiency virus (HIV) protease inhibitors; AIDS; prophylaxis |
12/23/2004 | US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence |
12/23/2004 | US20040259875 Incontinence; overactive bladder; neuropathic pain; neuralgia; analgesics; stroke; antiarthritic agents; antiinflammatory agents |
12/23/2004 | US20040259866 Calcium channel blockers comprising two benzhydril moieties |
12/23/2004 | US20040258720 Cosmetics; skin disorders, antiinflammatory agents |
12/23/2004 | CA2526387A1 Benzamide derivative or salt thereof |
12/22/2004 | EP1487796A1 Substituted biaryl amides as c5a receptor modulators |
12/22/2004 | EP1487794A1 Monocyclic aroylpyridinones as antiinflammatory agents |
12/22/2004 | EP1487785A2 Novel florfenicol-type antibiotics |
12/22/2004 | EP1366041A4 Preparation of n-methylparoxetine and related intermediate compounds |
12/22/2004 | EP1086072A4 Process for the preparation of protected dihydroxypropyl trialkylammonium salts and derivatives thereof |
12/22/2004 | CN1556788A Muscarinic agonists |
12/22/2004 | CN1181065C Aralkylformylakyl piperazine derivative and its application as brain nerve protector |
12/21/2004 | US6833140 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity |
12/21/2004 | CA2317604C Matrix metalloprotease inhibitors |
12/21/2004 | CA2241904C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
12/16/2004 | WO2004108696A1 Method of manufacturing alkylene carbonate |
12/16/2004 | WO2004108673A2 Inhibitors of papilloma virus |
12/16/2004 | US20040254237 Acid amide derivatives, process for producing these, and pest agent containing these |
12/16/2004 | US20040254165 Vitiligo; skin cancer; control skin coloring |
12/16/2004 | US20040254149 Antiproliferative agents; antiinflammatory agents; anticancer agents; diagnosis, therapy |
12/16/2004 | CA2526506A1 Inhibitors of papilloma virus |
12/15/2004 | EP1486486A2 Substituted B-thiocarboxylic acids |
12/15/2004 | EP1485387A1 Carbamates as hiv protease inhibitors |
12/15/2004 | EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase |
12/15/2004 | EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
12/15/2004 | EP1485353A1 New inhibitors of histone deacetylase |
12/15/2004 | EP1485099A1 Inhibitors of histone deacetylase |
12/15/2004 | EP1485089A1 Combination treatments for chemokine-mediated diseases |
12/15/2004 | CN1554653A Process for producing L-(S) propylidene glycerin aldehyde solution |
12/15/2004 | CN1554652A Method for producing L-(R) propylidene glycerin |
12/15/2004 | CN1179959C Intermediate of high-carbon saccharide compound and its synthesis and use |
12/14/2004 | US6831199 Pyrimidine compounds and derivatives thereof |
12/14/2004 | US6831193 Trisubstituted-N-[(1S)-1,2,3,4-Tetrahydro-1-naphthalenyl]benzamides which inhibit P2X3 and P2X2/3 containing receptors |
12/14/2004 | US6831186 Antiinflammatory agents; autoimmune disease |
12/14/2004 | US6831093 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof |
12/14/2004 | US6831080 Cinnamide derivatives as KCNQ potassium channel modulators |
12/14/2004 | US6830789 Possess a helical twist power substantially independent of temperature. naphthalene substituted dioxolane derivatives, especially (4R,5R)-2,2-dimethyl-a,a,a',a'-tetrakis(6-(benzyl-oxy)naphth-2-yl)-1,3 -dioxolane-4,5-dimethanol. |
12/09/2004 | WO2004106289A1 Protease inhibitors |
12/09/2004 | WO2004092106A3 Process for preparing alkoxy- and aryloxy-phenols |
12/09/2004 | WO2004078144A3 Diphenylethylene compounds and uses thereof |
12/09/2004 | US20040249098 (Meth)acrylic and (meth)acrylamide monomers comprising cyclic acetal/thioacetal groups, polymerizable compositions, and polymers obtained |
12/09/2004 | US20040248963 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives; nervous system, psychological, and psychiatric disorders |
12/09/2004 | US20040248031 5-Methylene-1,3-dioxolan-4-one derivatives, process for their production, polymers of the derivatives, resist compositions, and pattern formation process |
12/08/2004 | EP1484316A1 Novel propionic acid derivative |
12/08/2004 | EP1482926A2 Amino-methyl substituted tetracycline compounds |
12/08/2004 | EP0920312B1 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents |
12/08/2004 | CN1178897C Fungicidal compounds having fluorovinyl-or-fluoropropenyl-oxyphenyloxime moiety and process for preparation thereof |
12/07/2004 | US6828446 Aromatic thioether liver X-receptor modulators |
12/07/2004 | US6828445 Process for the preparation of baccatin III derivatives |
12/02/2004 | WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors |
12/02/2004 | US20040242928 Reverse hydroxamic acid derivatives |
12/02/2004 | US20040242903 Process for preparation of cyclic carbonate |
12/02/2004 | US20040242584 Muscarinic agonists |
12/02/2004 | US20040242574 Anticancer agents; antiarthritic agents |
12/02/2004 | US20040242563 potent, selective and safe inhibitors of Ca2+-activated potassium channel (Gardos channel) of erythrocytes, particularly sickle erythrocytes, and/or of mammalian cell proliferation for treating or preventing cancer, blood vessel proliferative disorders, fibrotic disorders and arteriosclerotic conditions |
12/02/2004 | US20040242410 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same |
12/01/2004 | EP1481968A2 Cell adhesion-inhibiting anti-inflammatory and immune-suppressive compounds |
12/01/2004 | EP1480941A2 Urea derivatives as hiv aspartyl protease inhibitors |
12/01/2004 | EP1246625B1 Uses and compositions of nitrate esters for providing sedation |
12/01/2004 | EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds |
12/01/2004 | CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides |
12/01/2004 | CN1177814C Method for preparing trion-bis (oxime ether) derivs. and trion-mono and trio-bis (oxmide ether) derivs. obtained therewith |
11/30/2004 | US6825377 Catalytic oxidation using oxygen or gas mixture in presence of osmium, ruthenium, or manganese compound in water; adding amine for catalyst selectivity |
11/30/2004 | US6825231 Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising them |
11/30/2004 | US6825226 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias |
11/30/2004 | US6825185 Improving the cardiovascular profile of a cox-2 selective inhibitor by administering with 3-hydroxy-3- methylglutaryl coenzyme a, an antiplatelet agent, a thrombin inhibitor or a thromboxane inhibitor |
11/25/2004 | WO2004101476A1 Metathesis reaction involving the unsaturated side chain of an alpha, alpha-disubstituted amino acid |
11/25/2004 | US20040236136 Low corrosive integrated process for preparing dialkyl carbonates |
11/25/2004 | US20040235962 Conformationally restricted polyamine analogs as disease therapies |
11/25/2004 | US20040235911 hydroxyamidines; antibiotic resistance |
11/25/2004 | US20040235908 Treating an a-chemokine mediated disease; melanoma, gastric carcinoma, and non-small cell lung cancer, gingivitis, respiratory viruses, herpes viruses, hepatitis viruses, HIV, kaposi's sarcoma associated virus and atherosclerosis |
11/25/2004 | US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases |
11/25/2004 | US20040235757 Anticarcinogenic and antimetastasis agents; leukemia or Hodgkin's disease. |
11/25/2004 | US20040234622 Sulfonamide derivatives |
11/24/2004 | EP1478613A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benz[a]anthracenes for selective effects on estrogen receptors |
11/24/2004 | EP1318976B1 Substituted aminopropoxyaryl derivatives useful as agonists for lxr |
11/24/2004 | EP1185536B1 Hemisynthetic method and intermediates thereof |
11/24/2004 | CN1548412A 3,7-disubstituted trans-dicyclo[3,3,0] octane compound and its prepn and use |
11/23/2004 | US6822000 Orthopedic implants or vehicles for the sustained delivery of pharmaceutical, cosmetic and agricultural agents contain hydrogen bonding groups and alpha-hydroxy acid-containing groups |
11/23/2004 | US6821965 Important in disease or medical conditions such as inflammation and immunoregulation |
11/18/2004 | WO2004099171A2 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
11/18/2004 | US20040230018 Fluorination and thermal decomposition at the 2-position of a 4-fluorosulfonyl-1,3-dioxolane to produce an addition polymerizable product for ion exchange membranes in solid fuel cells |
11/18/2004 | US20040229955 Antibacterial agents |
11/18/2004 | US20040229922 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
11/18/2004 | US20040229889 HDAC inhibitor |
11/18/2004 | US20040229872 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity |
11/18/2004 | CA2524927A1 Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same |
11/18/2004 | CA2523718A1 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
11/17/2004 | EP1476419A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
11/17/2004 | EP1289999B1 Antitumoral analogs of et-743 |
11/17/2004 | EP1283672B1 Antitubulin assembly and cell growth inhibitor denominated "dioxostatin" |
11/17/2004 | EP1042276B1 Thiourea compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis |